Amarin Corp Plc (AMRN)

[couldbebetter]

MRM, I always believed that AMRN had to be owned
by BP to succeed and I still believe that. Until that day
comes, I do not see sales of Vascepa taking off. (I do
hope I am wrong about that but given the performance of
Vascepa sales in Europe, the Middle-East, and China so
far I will need proof to drop my POV.) My hope for AMRN
rests on the new formulations. Will AD use them to lure in
a BP? Or, will they be laid to waste...The problem I see is
that the new formulations are best for their development to
be handled by a BP owner. BP is skilled at patent, legal, and
political protections. The sooner a BP can both build sales
and develop new formulations the better. Can AD do this?